This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Pathology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Huntington's chorea is characterised by cerebral atrophy with a marked loss of small neurones in the putamen and the caudate nucleus.

There are also changes in neurotransmitters in this disease:

  • reduction in enzymes that synthesise GABA and acetylcholine in the striatum
  • depletion of neurotransmitters in the substantia nigra, e.g. GABA, ACE and met-enkephalin
  • increase in somatostatin levels in the corpus striatum

At the cellular level, degenerating neurones have intranuclear inclusions of aggregated huntingtin protein. It is thought that the glutamine residues coded for by the expanded CAG repeats promote an amyloid-like aggregation of the protein.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.